A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours

NCT05057013 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer
Triple Negative Breast Cancer
Castration-resistant Prostate Cancer
Cervical Cancer
RAS Wild Type Colorectal Cancer
Endometrial Cancer
Gastric Cancer
Hepatocellular Carcinoma (HCC)
Melanoma
Non-small Cell Lung Cancer (NSCLC)
Oesophageal Cancer
Ovarian Cancer
Pancreatic Cancer
Squamous Cell Cancer of the Head and Neck

Interventions

DRUG: HMBD-001
DRUG: HMBD-001 and enzalutamide

Sponsor

Cancer Research UK

Collaborators

[object Object]